News

The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials, has been launched by The Pistoia Alliance, a non-profit organisation that promotes R&D collaboration...

Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction goals and hasten the implementation of net zero health systems. The Sustainable Markets Initiative (SMI) Health...

The majority of consumers base their first impression of a business and its sustainability credentials on the product packaging. With a third of UK consumers prepared to pay more for sustainable goods and services, the distinction between single-use, non-recyclable, and...

According to a market analysis, the global oral solid dosage (OSD) contract manufacturing market is forecast to grow $54.7 billion in value by 2030, growing at a compound annual growth rate (CAGR) of 6%. Oral solids are the most popular...

The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based research and development and focusing on the key diseases that impact people in Africa, experts suggested at a recent...

A new cold chain facility being built by Etihad Cargo, Etihad Airport Services, and Abu Dhabi Airports will more than increase the carrier's pharmaceutical capability at the airport's cargo village. For Etihad Cargo's PharmaLife handling and storage operations, the new...

Due to safety concerns, advisors to the European Medicines Agency on November 11th suggested restricting the use of a class of frequently prescribed anti-inflammatory medications. This recommendation follows a comparable but more stringent decision made by American authorities last...